HSP RES INST INC has a total of 24 patent applications. Its first patent ever was published in 1996. It filed its patents most often in Canada, EPO (European Patent Office) and United States. Its main competitors in its focus markets biotechnology, organic fine chemistry and pharmaceuticals are AIMM THERAPEUTICS BV, MEDICAL & BIOLOGICAL LABORATORIES CO LTD and X BODY INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 6 | |
#2 | EPO (European Patent Office) | 6 | |
#3 | United States | 6 | |
#4 | Japan | 3 | |
#5 | WIPO (World Intellectual Property Organization) | 2 | |
#6 | Australia | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Organic fine chemistry | |
#3 | Pharmaceuticals | |
#4 | Measurement |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Microorganisms | |
#3 | Heterocyclic compounds | |
#4 | Therapeutic chemical compounds | |
#5 | Measuring microorganism processes | |
#6 | Analysing materials | |
#7 | Fermentation |
# | Name | Total Patents |
---|---|---|
#1 | Yura Takashi | 18 |
#2 | Yanagi Hideki | 17 |
#3 | Haze Kyosuke | 6 |
#4 | Matsumoto Shuji | 5 |
#5 | Sogo Kazuyo | 5 |
#6 | Yoshida Hiderou | 4 |
#7 | Mori Kazutoshi | 4 |
#8 | Shimamoto Nobuo | 3 |
#9 | Kurokawa Yoichi | 3 |
#10 | Mori Tetsuya | 2 |
Publication | Filing date | Title |
---|---|---|
JP2005139066A | 2,3-dihydroxy-1h-quinolin-4-one oxime derivative and heat shock protein expression induction inhibitor | |
JP2001238699A | Method of screening orp150 expression-controlling substance | |
JP2001174463A | Method of diagnosing autoimmune disease or tumor | |
US6635751B1 | Isolated nucleic acids encoding activated and suppressive forms of ATF6 | |
CA2273081A1 | Method for screening heat shock protein expression induction regulators |